š¬ Current Disease Focus:
Task Progress: 0%
š„ Active Problem Solvers
0
š Experts collaborating globally
ā” Current Task Assignment
š§¬ Genetic Analysis
š Matching experts to specific tasks
š Resource Allocation by Research Phase:
š Data Analysis
š§Ŗ Experimental Design
š¬ Clinical Trials
š Treatment Development
The purpose of this study is to compare the immune response, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-05
Trial ID
NCT00290303
Treatments Being Tested
This study will be conducted in two stages. In the diphtheria, tetanus, per...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06-16
Trial ID
NCT00228917
Treatments Being Tested
The purpose of this study is to describe the safety and immunogenicity of M...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-08-20
Trial ID
NCT07710872
To evaluate Immunogenicity and Safety of Adjuvant and Adjuvant-Free Meningo...
Status
Unknown
Location
Gaozhou Center for Disease Control and Prevention
Start Date
2016-08
Trial ID
NCT02919293
This is a Phase 3, modified double-blind, randomized, parallel-group, activ...
Status
Active Not Recruiting
Location
Investigational Site Number : 1561000
Start Date
2025-09-26
Trial ID
NCT07135986
Treatments Being Tested
The purpose of this study is to compare the reactogenicity \& safety of Tri...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-12-11
Trial ID
NCT00317135
Treatments Being Tested
This study will only include infants born to mothers who are tested as sero...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-10
Trial ID
NCT00317122
Treatments Being Tested
The purpose of the study is to demonstrate consistent results in 3 producti...
Status
Completed
Location
GSK Investigational Site
Start Date
2004-08
Trial ID
NCT00317161
Treatments Being Tested
The purpose of the study is as follows: * To evaluate the persistence of a...
Status
Completed
Location
GSK Investigational Site
Start Date
2003-07
Trial ID
NCT00317174
Treatments Being Tested
The purpose of the study is to evaluate the immunogenicity, safety and reac...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-01-22
Trial ID
NCT00136604
Treatments Being Tested